122 related articles for article (PubMed ID: 3238308)
1. [The percentage of bone marrow plasmacytes and prognosis in multiple myeloma].
Paule B; Quillard J; Bennet P; Bisson M; Massias P
Rev Rhum Mal Osteoartic; 1988 Dec; 55(12):969-72. PubMed ID: 3238308
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P
Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
Pasqualetti P; Colantonio D; Casale R
Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic and therapeutic significance of bone marrow biopsy in multiple myeloma. Analysis of 31 stage II A and III A patients].
Paule B; Quillard J; Medicis P; Bourgeois P; Grossin M; Bisson M; Kahn MF
Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):27-32. PubMed ID: 3353673
[TBL] [Abstract][Full Text] [Related]
5. Role of MRI for the diagnosis and prognosis of multiple myeloma.
Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic application of sequential bone marrow biopsy in myeloma: analysis of 13 medullary biopsies].
Paule B; Médicis P; Clerc D; Bennet P; Bisson M; Massias P
Biomed Pharmacother; 1986; 40(7):261-4. PubMed ID: 3814757
[TBL] [Abstract][Full Text] [Related]
7. Significance of nucleo-cytoplasmic maturation asynchrony in multiple myeloma.
Scudla V; Wiedermann B; Kodousek R; Dusek J; Kamarád V; Indrák K
Neoplasma; 1986; 33(4):483-92. PubMed ID: 3762809
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
9. [Utility of the examination of plasma-cell morphology in the study of multiple myeloma].
Moro MJ; Portero JA; Gascón A; Hernández JM; Ortega F; Jiménez R; Guerras L; Martínez M; Casanova F; Sanz MA
Sangre (Barc); 1992 Jun; 37(3):175-9. PubMed ID: 1440094
[TBL] [Abstract][Full Text] [Related]
10. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
[TBL] [Abstract][Full Text] [Related]
12. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
Kumar S; Rajkumar SV; Greipp PR; Witzig TE
Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
[TBL] [Abstract][Full Text] [Related]
13. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
Paule B; Quillard J; Bennet P; Mariette X; Bisson M
Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in IgG and micromolecular multiple myeloma. Retrospective analysis of 50 consecutive cases].
Pasqualetti P; Casale R; Colantonio D; Festuccia V; Di Lauro G; Natali G
Minerva Med; 1987 May; 78(9):603-8. PubMed ID: 3587727
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
Sezer O; Heider U; Zavrski I; Possinger K
Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
[TBL] [Abstract][Full Text] [Related]
16. [Classification, staging and prognostic indices for multiple myeloma].
Hotta T
Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256
[TBL] [Abstract][Full Text] [Related]
17. Significance of bone marrow fibrosis in multiple myeloma.
Subramanian R; Basu D; Dutta TK
Pathology; 2007 Oct; 39(5):512-5. PubMed ID: 17886102
[TBL] [Abstract][Full Text] [Related]
18. [The prognostic significance of cytological study of the bone marrow in multiple myeloma].
Iakovleva SV
Ter Arkh; 2000; 72(7):48-51. PubMed ID: 10983321
[TBL] [Abstract][Full Text] [Related]
19. Histomorphology of multiple myeloma on bone marrow biopsy.
Singhal N; Singh T; Singh ZN; Shome DK; Gaiha M
Indian J Pathol Microbiol; 2004 Jul; 47(3):359-63. PubMed ID: 16295424
[TBL] [Abstract][Full Text] [Related]
20. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]